Immunomodulation and Tissue Compatibility
Two key ideas in the fields of medicine and transplantation are immunomodulation and tissue compatibility. Let's examine each idea in detail:
Immunomodulation: The process of altering or controlling the immune system's activity is known as immunomodulation. Protecting the body from hazardous organisms including bacteria, viruses, and foreign objects is the job of the immune system. To accomplish particular therapeutic objectives, it could be required to either boost or decrease the immune response in certain medical circumstances.
a. Immunosuppression, a type of immunomodulation, is the deliberate suppression of the immune system. To stop the recipient's immune system from fighting and rejecting the donated organ, it is frequently utilized in organ transplantation. To do this, immunosuppressant medications such corticosteroids and calcineurin inhibitors are taken.
b. Immunostimulation: In some circumstances, increasing the immune system's activity is necessary. Immunostimulants are substances that improve the body's defenses against illness or infection. Examples include immunocheckpoint inhibitors, which improve the body's natural defenses against cancer cells, and vaccinations, which encourage the immune system to develop antibodies against particular infections.
Histocompatibility, another name for tissue compatibility, describes how well the immune system of the recipient accepts a transplanted tissue or organ without rejecting it. The primary function of the immune system is to identify and destroy alien substances or cells, including transplanted tissues and organs. To avoid rejection and guarantee the long-term survival of the transplanted organ, tissue compatibility must be attained during organ transplantation.
Related Conference of Immunomodulation and Tissue Compatibility
Immunomodulation and Tissue Compatibility Conference Speakers
Recommended Sessions
- Regenerative Medicine Market
- Biomaterials and Bioengineering
- Dental and Craniofacial Regeneration:
- Gene and Immunotherapy
- Soft Tissue Replacement
- Tissue Repair and Regeneration
- .Bone Tissue Engineering
- Anti-Aging, Regenerative and functional Medicine
- Applications of Tissue Engineering
- Artificial Organs
- Bio Banking
- Biofabrication and 3D Printing
- Biomedical Engineering Techniques
- Biotechnology and nanotechnology in stem cells
- Cardiovascular Regeneration:
- Cell and Organ Regeneration
- Cellular and gene Therapies
- Clinical Applications and Translational Research:
- Emerging Technologies and Future Trends
- Global Perspectives and Healthcare Equity:
- Immunomodulation and Tissue Compatibility
- Musculoskeletal Regeneration:
- Neuro regeneration and Brain Repair:
- Regenerative Rehabilitation
- Stem Cell Bioprocessing
- Stem Cell Treatments
- Stem Cells and Regenerative Therapies:
- Tissue Engineering
- Tissue Engineering and Biomaterials
- Workshops and Interactive Sessions:
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
